Canada Post Corporation Pension Plan’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Hold
2,575
0.06% 237
2026
Q1
$1.99M Hold
2,575
0.08% 202
2025
Q4
$1.99M Buy
2,575
+1,200
+87% +$815K 0.08% 196
2025
Q3
$771K Buy
1,375
+160
+13% +$90.5K 0.03% 280
2025
Q2
$638K Buy
+1,215
New +$678K 0.04% 259
2025
Q1
Sell
-1,215
Closed -$865K 360
2024
Q4
$865K Buy
+1,215
New +$1.02M 0.05% 194

Other funds holding REGN

Canada Post Corporation Pension Plan's REGN Position: Q2 2026 in Review

Canada Post Corporation Pension Plan held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 2,575 shares worth $1.61M. The position accounts for 0.06% of the portfolio, ranked #237.

Canada Post Corporation Pension Plan first reported a position in REGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.99M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Canada Post Corporation Pension Plan held 2,575 shares of Regeneron Pharmaceuticals worth $1.61M as of Q2 2026.
  • Canada Post Corporation Pension Plan left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.06% of Canada Post Corporation Pension Plan's portfolio in Q2 2026, its #237 holding.
  • Canada Post Corporation Pension Plan first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Canada Post Corporation Pension Plan's Regeneron Pharmaceuticals position peaked at $1.99M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Canada Post Corporation Pension Plan's 13F filing for Q2 2026, filed 15 Jul 2026.